Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Gearry

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
The Lancet. Gastroenterology & Hepatology|February 16, 2019
Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and DevelopmentJames A King, Fox E Underwood, Nicola Panaccione, et al.
The Lancet. Gastroenterology & Hepatology|April 5, 2025
Prevention and interception trials in inflammatory bowel disease: an international taskforce assessment on clinical trial designSailish Honap, Nelly Agrinier, Joana Torres, et al.
The American Journal of Gastroenterology|August 16, 2022
The Global Incidence of Peptic Ulcer Disease Is Decreasing Since the Turn of the 21st Century: A Study of the Organisation for Economic Co-Operation and Development (OECD)Hassan Azhari, James A King, Stephanie Coward, et al.
Journal of Psychosomatic Research|July 4, 2021
The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative studyNuno Ferreira, Antonina Mikocka-Walus, Miranda A L van Tilburg, et al.
Cell|September 17, 2013
Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathwayJames C Lee, Marion Espéli, Carl A Anderson, et al.
Gastroenterology|July 1, 2018
Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western CountriesShailja C Shah, Hamed Khalili, Corinne Gower-Rousseau, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2025
DIAGNOSIS AND MANAGEMENT OF UPPER GASTROINTESTINAL INVOLVEMENT IN ADULT PATIENTS WITH CROHN'S DISEASE: A SYSTEMATIC REVIEWNathaniel A Cohen, Neta Sror, Maliha Naseer, et al.
Gut|November 1, 2016
Development of an index to define overall disease severity in IBDCorey A Siegel, Cynthia B Whitman, Brennan M R Spiegel, et al.
The Lancet. Gastroenterology & Hepatology|January 11, 2026
Definitions, diagnosis, management, and outcomes of upper gastrointestinal Crohn's disease: an international, expert RAND/UCLA appropriateness studyNathaniel A Cohen, Dominik Bettenworth, Neta Sror, et al.
Journal of Crohn'S & Colitis|December 2, 2015
Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel DiseaseGraham A Heap, Kenji So, Mike Weedon, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
The Lancet. Gastroenterology & Hepatology|February 16, 2019
Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and DevelopmentJames A King, Fox E Underwood, Nicola Panaccione, et al.
The Lancet. Gastroenterology & Hepatology|April 5, 2025
Prevention and interception trials in inflammatory bowel disease: an international taskforce assessment on clinical trial designSailish Honap, Nelly Agrinier, Joana Torres, et al.
The American Journal of Gastroenterology|August 16, 2022
The Global Incidence of Peptic Ulcer Disease Is Decreasing Since the Turn of the 21st Century: A Study of the Organisation for Economic Co-Operation and Development (OECD)Hassan Azhari, James A King, Stephanie Coward, et al.
Journal of Psychosomatic Research|July 4, 2021
The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative studyNuno Ferreira, Antonina Mikocka-Walus, Miranda A L van Tilburg, et al.
Cell|September 17, 2013
Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathwayJames C Lee, Marion Espéli, Carl A Anderson, et al.
Gastroenterology|July 1, 2018
Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western CountriesShailja C Shah, Hamed Khalili, Corinne Gower-Rousseau, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2025
DIAGNOSIS AND MANAGEMENT OF UPPER GASTROINTESTINAL INVOLVEMENT IN ADULT PATIENTS WITH CROHN'S DISEASE: A SYSTEMATIC REVIEWNathaniel A Cohen, Neta Sror, Maliha Naseer, et al.
Gut|November 1, 2016
Development of an index to define overall disease severity in IBDCorey A Siegel, Cynthia B Whitman, Brennan M R Spiegel, et al.
The Lancet. Gastroenterology & Hepatology|January 11, 2026
Definitions, diagnosis, management, and outcomes of upper gastrointestinal Crohn's disease: an international, expert RAND/UCLA appropriateness studyNathaniel A Cohen, Dominik Bettenworth, Neta Sror, et al.
Journal of Crohn'S & Colitis|December 2, 2015
Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel DiseaseGraham A Heap, Kenji So, Mike Weedon, et al.
Pageof 8